technetium (99mTc) exametazime
GPTKB entity
Statements (24)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
radiopharmaceutical
diagnostic agent |
| gptkbp:approvedBy |
gptkb:FDA
1986 |
| gptkbp:ATCCode |
V09AA02
|
| gptkbp:containsElement |
gptkb:technetium-99m
|
| gptkbp:detects |
stroke
brain death abscesses inflammatory lesions |
| gptkbp:excretion |
renal
hepatobiliary |
| gptkbp:halfLife |
6 hours (technetium-99m)
|
| https://www.w3.org/2000/01/rdf-schema#label |
technetium (99mTc) exametazime
|
| gptkbp:imagingModality |
gptkb:SPECT
|
| gptkbp:ligand |
exametazime
|
| gptkbp:marketedAs |
Ceretec
|
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:synonym |
99mTc-HMPAO
Ceretec |
| gptkbp:usedFor |
cerebral perfusion imaging
leukocyte labeling |
| gptkbp:bfsParent |
gptkb:V09AB03
|
| gptkbp:bfsLayer |
8
|